Heart drug digoxin explored for alcohol hepatitis – study halted
NCT ID NCT05014087
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked at whether digoxin, a heart medication, could lower inflammation in people with severe alcohol-related hepatitis. 23 adults were randomly assigned to receive digoxin or no digoxin for up to 28 days. The study was stopped early, but researchers measured changes in inflammatory markers to see if digoxin might help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ALCOHOLIC HEPATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Yale New Haven Hospital, Yale School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.